Article: Exploring the Future Trends of Schering-Plough Corp.

M2 PRESSWIRE-4 December 2006-Biotech News: Exploring the Future Trends of Schering-Plough Corp.(C)1994-2006 M2 COMMUNICATIONS LTD

RDATE:04122006

Exploring the Future Trends of Schering-Plough Corp. (NYSE:SGP)

Schering-Plough can get rid of the most embarrassing ailments -- runny noses, sunburned shoulders, and fungal feet. The druggernaut develops and markets prescription and OTC drugs, animal health products, and personal care products. Although the company is best known for its allergy medications Clarinex and Nasonex, the company specializes in anti-infectives (particularly for hepatitis) and cancer drugs. The drugmaker co-promotes erectile ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!